Yasmine Wasfi - 04 Dec 2025 Form 4 Insider Report for Savara Inc (SVRA)

Reporting relationship: Chief Medical Officer
Issuer ticker: SVRA
Reported as of: 04 Dec 2025
Net transaction value: -$140,089
SEC form: 4
Accepted by SEC: 04 Dec 2025, 18:57:10 UTC
Prior SEC filing: 22 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Kate McCabe as attorney-in-fact for Yasmine Wasfi

Key filing fact

Yasmine Wasfi filed Form 4 for Savara Inc (SVRA) on 04 Dec 2025.

Key facts

This page summarizes Yasmine Wasfi's Form 4 filing for Savara Inc (SVRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Dec 2025, 18:57.

Change

Previous filing in this sequence was filed on 22 Oct 2025.
Current net transaction value: -$140,089.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002092127 Primary reporting owner

Wasfi Yasmine

Relationship: Chief Medical Officer
Address: ONE SUMMIT SQUARE,, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300, LANGHORNE
Signature: /s/ Kate McCabe as attorney-in-fact for Yasmine Wasfi
Signature date: 04 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SVRA transaction

Common Stock

Tax liability

Transaction value: $140,089
Shares: -21,992
Change %: -12%
Price: $6.37
Shares after: 168,008
Date: 04 Dec 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units.